Millions of people’s DNA up for sale as 23andMe goes bankrupt
Millions of people will have their DNA data for sale after the main household test company 23 and submitted for bankruptcy.
The company, which tested more than 15 million folk genetic makeup, using Psel’s salivation, including more than 250,000 in the UK, said that the company had entered the US bankruptcy protection.
It is said that the confidentiality of data would be “important attention”, but added that it strives to “maximize the value of its assets.”
Privacy lawyers have urged consumers to delete their 23andme data Because the company’s stock accident caused fears that the data can be sold to data brokers or targeted advertising.
On Friday, the California Prosecutor General Rob Bonta said that customers should take into account the erasing their profiles.
Announcing that it had applied for bankruptcy protection, 23andme said:
23andme, which is riding a DNA testing boom to appreciate $ 6 billion (4.6 billion) in 2021, has seen its cost of only $ 48 million. Revenues have decreased as tests that show the origin of the ancestors and the risks of genetic health, go out of fashion.
He lost $ 667 million a year until March 2024, at the end of September, he had cash worth $ 127 million.
23andme advice said it rejected the third occupation bid Ann Wjciki, the CEO of the company and founder. The offer was estimated at $ 2.94 a share of $ 2.94 million, but depended on the company that hits certain income targets.
Ms. Wjciki said that he had resigned as a chief executive and intended to apply to the company as part of the sales process.
The company’s President Mark Jensen said.
The company reports:
23andme has already been accused of entering the data of the users of hackers since the risk after risking the names of Chinese or Ashkhenaz Jewish Heritage.
In September last year, it agreed to pay $ 30 million to the lawsuit for the violation. The company provided $ 35 million in funding to maintain function.
23andme has a research agreement with the GSS that seeks to use the data to invent new types of drugs. The pharmaceutical company has the option to extend the transaction at the end of this year.
English